Compound ID | 1274
NBTI
Class: Bacterial topoisomerase inhibitor
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Acinetobacter + P. aeruginosa + Enterobacteriaceae infections. |
| Institute where first reported: | Redx Pharma |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| External links: | |
| Citation: | https://carb-x.org/wp-content/uploads/2019/05/2019.05.21-Portfolio-Pipeline-Formerly-Funded.pdf |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.